LifeMD delays Q3 2026 10-Q filing to correct revenue and expense recognition errors
LFMD•LifeMD delayed its Q3 2026 10-Q filing to correct revenue and expense recognition errors. The company is evaluating the errors’ impact on disclosure controls and internal control over financial reporting.
1. Filing delay
LifeMD delayed its Q3 2026 10-Q filing because it needs to correct revenue and expense recognition errors. The company is evaluating the errors’ impact on disclosure controls and internal control over financial reporting.
